1394029-14-1 Usage
Classification
Antibiotic
Belongs to the fluoroquinolone class
Spectrum
Broad-spectrum
Effective against a variety of bacterial infections
Mechanism of action
Inhibition of bacterial DNA replication and repair
Interferes with the bacteria's ability to replicate and repair their DNA, leading to cell death
Common uses
Treatment of infections in urinary tract, respiratory tract, skin, and gastrointestinal system
Used for a wide range of bacterial infections
Forms
Oral and intravenous
Available in different forms for administration
Treatment status
Second-line treatment
Often used when other antibiotics have proven ineffective
Side effects
Nausea, diarrhea, and photosensitivity
Generally well-tolerated but can cause some side effects
Check Digit Verification of cas no
The CAS Registry Mumber 1394029-14-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,9,4,0,2 and 9 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1394029-14:
(9*1)+(8*3)+(7*9)+(6*4)+(5*0)+(4*2)+(3*9)+(2*1)+(1*4)=161
161 % 10 = 1
So 1394029-14-1 is a valid CAS Registry Number.
1394029-14-1Relevant articles and documents
Moxifloxacin of a preparation or a pharmaceutically acceptable salt, wherein the method of the midbody
-
Paragraph 0037-0038, (2017/03/28)
The invention provides a novel method for preparing moxifloxacin or its medicinal salt and its intermediate, which comprises the following steps: dissolving boron trioxide in a certain amount of acetic anhydride and an acetate mixing solution, reacting under the temperature of 90-120 DEG C, cooling a reaction solution; adding cyclized quinolinecarboxylic ester in the reaction solution and reacting at the reaction temperature of 50-80 DEG C, cooling, adding a certain amount of an ether solvent, stirring and then filtering, washing by the ether solvent, drying to obtain the product; reacting with (4aR, 7aR)-octahydropyrrolo[3,4-b]pyridine to obtain the moxifloxacin or its medicinal salt. The reaction method of the invention is mild and controllable, the common equipments enable production, the obtained product has the advantages of high purity and good color, boron oxide substitutes boric acid for chelating to reduce the damage of equipments and human body caused by acid mist in the reaction.
